alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                     Exhibit 1.1
                            CERTIFICATION PURSUANT TO
                SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

I, Ronan O'Caoimh, certify that:


1. I have reviewed this annual report on Form 20-F of Trinity Biotech plc;


2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;


3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;


4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 15(d)-15(e)) for the registrant and we have:


a) designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this annual report is being prepared;


b) evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this annual report based on such evaluation ; and


c) disclosed in this annual report any change in the registrant's internal
control over financial reporting that occurred during the registrant's fourth
fiscal quarter that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting.


5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent function):


a) all significant deficiencies and material weaknesses in the design or
operation of internal controls over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and


b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date:  March 31, 2004

RONAN O'CAOIMH *
--------------------------------------------------------------------------------
Chief Executive Officer

        * The originally executed copy of this Certification will be maintained
at the Company's offices and will be made available for inspection upon request.
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          OCT-31-1999
<PERIOD-START>                             NOV-01-1998
<PERIOD-END>                               JUL-31-1999
<CASH>                                          51,816
<SECURITIES>                                         0
<RECEIVABLES>                                   32,442
<ALLOWANCES>                                     1,422
<INVENTORY>                                     18,520
<CURRENT-ASSETS>                               103,101
<PP&E>                                          10,737
<DEPRECIATION>                                   3,628
<TOTAL-ASSETS>                                 114,713
<CURRENT-LIABILITIES>                           16,286
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            88
<OTHER-SE>                                      96,930
<TOTAL-LIABILITY-AND-EQUITY>                   114,713
<SALES>                                        111,219
<TOTAL-REVENUES>                               111,219
<CGS>                                           82,922
<TOTAL-COSTS>                                   82,922
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   841
<INTEREST-EXPENSE>                                  20
<INCOME-PRETAX>                                 29,417
<INCOME-TAX>                                    11,766
<INCOME-CONTINUING>                             17,651
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    17,651
<EPS-BASIC>                                       2.01
<EPS-DILUTED>                                     1.86


</TABLE>
• 

.. .. ,, " 

MEMO ROUTING SLIP 

'E'O-SO(,\ 

TO: General.Corderman 

The easy solution to the question of whether or not to 

permit declassification of the patent application on the 228 

is to deny declassification. The issue is one that is not unique. What to do about atomic bombs, proximity fuses, 209's, and probably thousands of other items of equipment is claiming the 

attention of many people. 

I've thought about this particular question for a long time 

and discussed it at length with Horton and Prehn. Prehn and 

Myers have written their opinions. Myers is now opposed to dec~assif1cation. Prehn wants to ~eaerve judgment. Horton is 

opposed. 

But I'm inclined to declassify the equipment for several 

reasons: 

1. It is understood by a great many Bell System repairmen. 

2. The Bell System, if it desires to provide enciphered 

teletype service, may manufacture identical equipment with 

impunity until patents are issued or with its genius for getting around patents make minor changes and use an almost identical machine even if the 228 is·. patented. · 

3. The 228 is not our best cryptographic equipment. 

4. P~ans are already under way to supersede it. ~ 

5. The temptation to rest on our laurels will be less 

if we know that some of our important equipments are publicly 

used. 

6. Like·a11 other cryptographic equipment, the real 

security comes ·from the frequently changing key and keying 

element. 

• 

If, as I believe, the above argument is valid, then I 

believe that the inventors should receive patent protection and 

the right to exploit their invention. 

@'pproved for Release by NSA on 09-13-2013 

. . C'f' ~?~y '°'~<.Ir· :4 . ':a~,. 'f 

. -. tii 

pursuant to E .o. 1352a 
REF ID:A104760 e 

There is only one alternative and that is for the government to retain exclusiye use of the device and to compensate 

the inventors. I cannot ~eel that compensation would ever be 

more than a hope. 

I suggest that you conduct a discussion of the problem 

with Friedman, Rowlett, Myers, Prehn, Horton, me and such other 

people as may be able to contribute something to the solution. 

/s/ M. G. Jones, Colonel 

25 Oct 1945 

r.(' .. ·f~ iy ;·.:i;.~ \\ ·.~ ' . . . (',' ;.: ;. _.. 'fe;..
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>  This Schedule contains summary financial information extracted from
the consolidated balance sheets and consolidated statements of operation and
is qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1
       
<S>                            <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                  DEC-31-1998
<PERIOD-START>                     JAN-01-1998
<PERIOD-END>                       DEC-31-1998
<CASH>                               2,913,000
<SECURITIES>                                 0
<RECEIVABLES>                        9,733,000
<ALLOWANCES>                         2,160,000
<INVENTORY>                                  0
<CURRENT-ASSETS>                     2,237,000
<PP&E>                             584,883,000
<DEPRECIATION>                      59,793,000
<TOTAL-ASSETS>                     546,516,000
<CURRENT-LIABILITIES>               10,443,000
<BONDS>                            350,141,000
<COMMON>                           116,094,000
<PREFERRED-MANDATORY>                        0
<PREFERRED>                         68,385,000
<OTHER-SE>                                   0
<TOTAL-LIABILITY-AND-EQUITY>       546,516,000
<SALES>                                      0
<TOTAL-REVENUES>                    71,451,000
<CGS>                                        0
<TOTAL-COSTS>                       45,808,000
<OTHER-EXPENSES>                             0
<LOSS-PROVISION>                             0
<INTEREST-EXPENSE>                  21,764,000
<INCOME-PRETAX>                              0
<INCOME-TAX>                                 0
<INCOME-CONTINUING>                          0
<DISCONTINUED>                               0
<EXTRAORDINARY>                              0
<CHANGES>                                    0
<NET-INCOME>                         3,879,000
<EPS-PRIMARY>                             0.37
<EPS-DILUTED>                             0.37

        

</TABLE>
REF ID:A66023 

e 

THE INSTITUTE FOR ADVANCED STUDY 

PRINCETON, NEW JERSEY 

SCHOOL OF MATHEMATICS June 20, 1951 

Dear Colonel Collins: 

Thank you for your letter of June 18, and the papers 

that came with it. I need not tell you that they interest 

me a great deal, and that I am very glad that there may be 

an occasion !or me to help you in the work of the AFSA. 

Sincerely yours, 

John von Neumann 

JvN:eg 

Colonel S. P. Collins~ Acting Director 

Armed Forces Security Agency 

Department of Detense 

Washington 25, D. C. 

Attn: AFSA-000:/ef 

Serial: 00509 

Declassified and approved for release by NSA on 04-15-2014 pursuantto E .0. 1352a 

- .., 

.: 
REF ID: A6602,3.... 

-· 

Proteasor John von !eumann 

Institute tor .Ad:vanced Stud7 

Princeton, lft' Jeraey 

Dear Professor TOD. Weumann: 

'::--" .. 

• "" "7 .. - • 

as1i:--oar/er 

Serial.I 00309 

18 JUN 1951 

I• enclosing herewith, in accordance with a request ot 

Dr. · Campaigne of this Apnc7, cert.ain pu.blicationa which ._,. be ot 

use to J'OU• Inasmuch as the• publlcat.iona are not di•tributed. 

outaide the Ar;.encr e.zcept uni.er circmutance• aucb as the preeent 

one, I ehall liave to ask that J'OU restrict their uae in accordance 

wlttl the eecurit.7 regulationa applicable to SCAC. Will J'OU be eo 

Coed aa to aign the enclosed receipt and return it to • at JOU?" 

earliest convenience? 

. lfar I take this opportun1t7 to thank 70'1 tor 7ou.r attendance 

at t'1e tint SCAG Conference, &IJd tor the visit which 70u recent.q med~ to t.hia Apnc7. I Biil certa1.n that SCAG wlll be able to contribute much to the solution ot cert.a.in problena confronting ua, 

and J'OU1' interest ia part.icularl,y Fatitr1ng. We ahall look 

t0l"Wfr4. to ,ee:lpg 7ou, 1t ;your schedule permits, at the next meethg ot SCIG- on 10 Ju.17. 

8:incere}1' J"OUl'B, 

i~1s document contains intormation 

ettecting the national defense of 

the United States within the meaning ot the Espi.cna·r.e Laws, !it1e 18, r.io:;r; =Corps u.s.o.' Seotiori. ·;• J:5 and 794. !he Acting .at..r.ctor. 

t'l'ansmisaion or the revelation o'f Armed rorcee S.Cu:dt, Aprq 

it• oontents in 8'lrf mamier t.o an 

uaau.tbO•ised person is proh1bite4 

\'ty' laW .. 

!See llso Public Law 513, 

,81 Congress second sess:·m 

' PLEASE RETURN TO AFSA-OOT 

William F. Friedman/ef/lS Jun 51 

AFSA-OOT, Ext 60240
Exhibit 32.1
 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
 (2)
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
  /s/ Stephen C. JumperStephen C. JumperPresident and Chief Executive Officer

(principal executive officer)
<PAGE>   1
                                                                  EXHIBIT 11.1



                UNIVERSAL STANDARD MEDICAL LABORATORIES, INC.
               COMPUTATION OF CONSOLIDATED NET INCOME PER SHARE
                   (In thousands, except per share amounts)


<TABLE>
<CAPTION>
                                                                    Years Ended
                                                                    December 31,
                                                         1996           1995            1994
<S>                                                     <C>          <C>              <C>
Income (loss) before extraordinary loss (a)             ($7,751)       ($981)         ($1,954)
Extraordinary loss (a)                                       *            *               167
Net income (loss) (a)                                   ($7,751)       ($981)         ($2,121)

PRIMARY SHARES
Weighted average common shares outstanding                6,462        6,251            6,225

Effect of assumed exercise of stock options at prices
which are lower than the average market price of
common shares during the period using the
treasury stock method                                                    105              142

Warrants outstanding                                                      36               50

Average shares outstanding and common equivalent
shares for primary earnings per share                     6,462        6,392            6,417

PRIMARY EARNINGS PER SHARE (a):
Income (loss) before extraordinary loss                 ($1.199)     ($0.153)         ($0.305)
Extraordinary item                                          *             *           ($0.026)
Net Income (loss)                                       ($1.199)     ($0.153)         ($0.331)

FULLY DILUTED SHARES

Weighted average common shares outstanding                6,462        6,251            6,225

Effect of assumed exercise of stock options at
prices which are lower than the market price of
common shares at the end of the period, when the
ending price is higher than the average market price                     106              151

Warrants outstanding                                                      36               51

Average shares outstanding and common equivalent
shares, assuming full dilution                            6,462        6,393            6,427

FULLY DILUTED EARNING PER SHARE:
Income (loss) before extraordinary loss                 ($1.199)     ($0.153)         ($0.304)
Extraordinary loss                                          *             *           ($0.026)
Net Income (loss)                                       ($1.199)     ($0.153)         ($0.330)
</TABLE>

(a) These amounts agree with the related amounts in the condensed consolidated
    statements of income.


*  Not applicable
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                         823,576
<SECURITIES>                                         0
<RECEIVABLES>                                  573,190
<ALLOWANCES>                                 (100,000)
<INVENTORY>                                  1,269,543
<CURRENT-ASSETS>                             2,755,084
<PP&E>                                      10,957,322
<DEPRECIATION>                               3,288,372
<TOTAL-ASSETS>                              10,424,034
<CURRENT-LIABILITIES>                        2,739,266
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                  1,000,000
<COMMON>                                    29,025,840
<OTHER-SE>                                (33,601,145)
<TOTAL-LIABILITY-AND-EQUITY>                10,424,034
<SALES>                                      2,663,633
<TOTAL-REVENUES>                             2,663,633
<CGS>                                        2,244,932
<TOTAL-COSTS>                                6,874,099
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           (761,108)
<INCOME-PRETAX>                            (4,971,574)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (4,971,574)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (4,971,574)
<EPS-PRIMARY>                                   (0.40)
<EPS-DILUTED>                                   (0.40)
        

</TABLE>
'- .. ., 

»x-~ a. 1. Wilka 

Dlputment ot MatbeJte.tic• 

Ju 1081 

~ 

tine Bit.ll 

tJniver•it)' 

hlnceton, kw Je:raer 

Deex- a...i 

' ~ --..... ~ ..,:_ . - "*' .... ----... , '•~"I ' , .. _.~...-.,_u-~-----.--.r: 

REF ID:A64297 

.. rw1 

On nsce1pt ot your letter ot Jt. loTembor l9~, OGDc:•~ Dr. Green, 

l Mnt it tQ Col.onol DH1lCW1 Si.oclail", Chief ot hnonnol. D1via1on, for 

~t. 1 Y1U ~to from hU JllmQf 

"Wblle tbo ki~bol.Oitcal lerrioea ~ &t EA 11 FQl.r81811'\ll 

ta~, • areat &le.lot work l"'Wa1n. M.roni 1u ¢0CijjlUt1on .M. w 

wuJA bo YerJ tat.e.r.-.at.e\\ in tuin1n1~ t.1W paibl.• ... oea.tton ot Dr. 

Creen 1'1tb w. FOJect, •baltld bt .mt to cwr t.1Jo .Uitarr MrYietit. 

•turo.l.l¥1 C#r1Ain d.e'ta!JA ~ tlr. Green*• prttHnt mtu.. at 

ho~ct IJ..neoln, hi• future ~t1ona'" .ui11'1• aillt.q ~· •tatu., 

u '1'.1.¥1 ~to be c.liu'iti4td.. t 'belirre thu vou.14 'M h&Adled. bfft 

»)r 4.treot co;aunication vith the l8A l"wnonnal DiviaiOP· 

~vor• tucll M froJ•at Lincoln u•uall7 poeae11 a ffT¥ b!&b 

pr1or1t11 ,art1cularl)" u ~ the ~nt ot ~ient1tic peX11Qmlel· n. ~ procedure u t.o ~icn a;a, ill41Vidua.l to that o:r a ~lated. 

M\ivtty vban bit~• m.Uit.q .t&t'WI. lnlil• tb.tt ~t cJl tbe 

4.1.tticulty vhich - VQUJ.d ~.llltA.l" in obtaiuing hiJI IOX'ViCff ruatna 

to b4l M!!m, ve au-e am.1awt tQ qplore the ~a!bilitiea rith nr. Or~n .. 

•,t am .-W:-• Pr. Yil.kt tuowe the.t w ~ U.. .,:;, poaition to NC'UX'e 

CQrni•tiona. Our interest would 'bo in~~ toi: Dr. Green•• &Ni&n9nt to ISA. one& bit bu •1*oted to &'tel' tr.e Qt tho tl:9l"'f1ect• ~ ~ 

~ha 'buic tra!rdrJ.S. tn tbi• ~et1on1 JISA•• chances ot 

pt tin& hia are .ucll. ..-t~r 1t be •lecta the J.rrJ/f',/. 

,,.lt would be ueetul it nr. Groen Wnt to •iti._ laA at ht• eonvenience, 

1 ct COUI'ff, t:t:.t hU Miu ~ him to Wuhiastoo on occuiou. 

tt • pel'aom.l n..1• 1• ~ conveD.iont.1 then 1t 1'0Ul.d be bolptW. U nr. Gl'Oe.n 

1'0Uld. kltep us advieed. of hi• p1a:uJ 'b;y i.tter a&1n•aed to the Af!UlcY and 

arked tor my t.ttent1on. I'! 

X VQUld a.1#0 be llad to Jlfft nr. Grnu in (!aM hi oai:ae• to vi•it 

u.. ~ i.t - Jmov. 

@'pproved for Release by NSA on 07-09-2014 pursuantto E.O. 1352a 
. ' J :" : 

-- --¥ - '°' 

REF ID:A64297 

A'bout to.xall'• •tdets, X haw V.titton but aa tar DO ... N. 

Xt'• a little too •orm, J aue••· \lh~ are rou co=t.nc cur_, •Int 

cc; AG 

c/s 

S/ ASST (Mr. Friedm!J.1)<~~ =-![ 

l'ERS (Col. Sinclair) 

M/R t On 4 Nov.. 19 54 Dr. 'W'ilka '\II'O l;.e to Mr~ ;Friedman euggesting 

that nr. Bert F. Green would. 'bo l'1n asset tothis >.sency if' 

h2 chose to enter the mil1to.ry service. Mr .. P'riedman 1a a.nswr 

aelt-e:cple.n9.to.:r:;r.
<HTML>
<HEAD>
<META NAME="Generator" CONTENT="Microsoft Word 97">
<TITLE>EXHIBIT 3</TITLE>
<META NAME="Template" CONTENT="C:\PROGRAM FILES\MICROSOFT OFFICE\OFFICE\html.dot">
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">

<B><U><FONT FACE="Times"><P ALIGN="RIGHT">Exhibit 3.1</P>
</B></U><P> </P>
<B><P ALIGN="CENTER">CERTIFICATE OF AMENDMENT TO THE</P>
<P ALIGN="CENTER">CERTIFICATE OF INCORPORATION OF</P>
<P ALIGN="CENTER">CPAC, INC.</P>
<P ALIGN="CENTER">Under Section 805 of the Business Corporation Law</P>
</B><P> </P>
<P>The undersigned being the President and Secretary of CPAC, Inc., do hereby certify and set forth:</P>
<P>            1.         The name of the Corporation is CPAC, Inc. The name under which the Corporation was originally formed is Computerized
Pollution Abatement Corporation.</P>
<P>            2.         The Certificate of Incorporation of the Corporation was filed by the Department of State on March 27, 1969.</P>
<P>            3.         The Certificate of Incorporation is hereby amended to effect an increase in the aggregate number of shares the Corporation
has the authority to issue. Article 7 of the Certificate of Incorporation is hereby amended to add an additional ten million (10,000,000) shares of common stock at $.01 par value to the existing twenty million (20,000,000) shares of common stock at
$.01 par value.</P>
<P>                        To effect these changes, Article 7 of the Corporation's Certificate of Incorporation is hereby amended to
read as follows:</P>
<P>                        "7. The aggregate number of shares which this Corporation shall have authority </P>
<P>                        to issue is thirty million (30,000,000) common shares, $.01 par value."</P>
<P><PAGE 21></P>
<P ALIGN="CENTER">- 2 -</P>
<P ALIGN="CENTER"> </P>
<P>            4.         This amendment to the Certificate of Incorporation was authorized by the unanimous vote of the Board of Directors followed
by the affirmative vote of the holders of a majority of all issued and outstanding shares entitled to vote thereon at the Annual Meeting of Shareholders duly called and held on August 11, 1999, a quorum being present.</P>
<P>            <B>IN WITNESS WHEREOF</B>, the undersigned have executed this Certificate this 19th day of August, 1999 and affirm under penalties of perjury that the foregoing statements are true
and complete.</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 WIDTH=576>
<TR><TD WIDTH="50%" VALIGN="TOP">
<P> </TD>
<TD WIDTH="50%" VALIGN="BOTTOM">
<U><FONT FACE="Times"><P>/s/ Thomas N. Hendrickson                        <BR>
</U>Thomas N. Hendrickson, President</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=49><P></P></TD>
<TD WIDTH="50%" VALIGN="TOP" HEIGHT=49><P></P></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<P> </TD>
<TD WIDTH="50%" VALIGN="TOP">
<U><FONT FACE="Times"><P>/s/ Robert Oppenheimer                             <BR>
</U>Robert Oppenheimer, Secretary</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="Times"><P><PAGE 22></P></FONT></BODY>
</HTML>
EXHIBIT 32.2

# CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Quarterly Report of Dotronix, Inc. (the Company) on Form
10-QSB for the year ended December 30, 2003 as filed with the Securities and Exchange
Commission (the Report), I, Robert V. Kling, Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of
the Sarbanes-Oxley Act of 2002, that:

(1)
   The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2)
   The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Dated:  February 19, 2004

| |                                        | /s/   Robert V. Kling |  | 
| | -------------------------------------- | --------------------- |  | 
| |                                       
| | Robert V. KlingChief Financial Officer |                      

17

---